Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

Expected use of approximately $25 million in first quarter of 2025 intended to preserve approximately 200,000 ADSs held as treasury shares ...

Ascendis Pharma A/S has a 52 week low of $111.09 and a 52 week high of $161.00. The stock’s fifty day moving average is $133.63 and its 200-day moving average is $132.89. About Ascendis Pharma A/S ...

Ascendis Pharma A/S has a 1 year low of $111.09 and a 1 year high of $161.00. The company has a 50 day simple moving average of $133.51 and a two-hundred day simple moving average of $132.77.

On January 15, Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company shared his outlook for 2025. He believes that the market has lost some of its momentum as the ...

Evercore ISI analyst Joshua Schimmer maintained a Buy rating on Ascendis Pharma (NASDAQ:ASND) on Tuesday, setting a price target of $210, which is approximately 57.27 ...

On Wednesday, Goldman Sachs reaffirmed its Buy rating on Ascendis Pharma (NASDAQ:ASND) shares with a price target of $200.00, well above the current trading price of $131.57. Analysts at the firm ...

In this article, we are going to take a look at where Ascendis Pharma A/S (NASDAQ:ASND) stands against other high growth international stocks to invest in now. On January 15, Jurrien Timmer ...

Walmart steel cage match (although we would totally watch). Instead, Walmart gave its logo a makeover fit for modern times—at least that was the idea. But people, well, they have feelings.

- Ascendis positioned to drive rapid revenue growth COPENHAGEN, Denmark, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update ...

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...